{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:10:10Z","timestamp":1756375810867,"version":"3.44.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016650","name":"Rare Diseases Clinical Research Network","doi-asserted-by":"publisher","award":["Rare Diseases Clinical Research Network"],"award-info":[{"award-number":["Rare Diseases Clinical Research Network"]}],"id":[{"id":"10.13039\/100016650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["National Institute of Neurological Disorders and Stroke"],"award-info":[{"award-number":["National Institute of Neurological Disorders and Stroke"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["National Center for Advancing Translational Sciences"],"award-info":[{"award-number":["National Center for Advancing Translational Sciences"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>There is increasing evidence of health outcome disparities due to inequitable healthcare. These inequities are likely compounded in rare disease care and research. We aimed to identify disparities in access to clinical care and research for patients with hereditary hemorrhagic telangiectasia (HHT) in North America.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We collected race data from the Toronto HHT Centre Brain Vascular Malformation Consortium (BVMC) recruits, the UCSF HHT Centre BVMC recruits, and the UCSF HHT Centre clinic patients, and compared proportions to local populations (2016 Canadian Census and 2010 San Francisco Bay Area Census).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>At the UCSF HHT center, there was a significant association between race and BVMC enrollment status (<jats:italic>p<\/jats:italic>\u2009=\u20090.033). The proportion of White BVMC recruits was significantly higher than reported in the SF Bay Area Census data (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). At the Toronto HHT centre the proportion of White BVMC recruits was significantly higher than reported in the Canadian Census provincial data (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and Toronto Metropolitan Area data (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We report preliminary evidence of racial differences in access to HHT care and research in North America. Our findings indicate a need for race data collection and reporting, as well as identification of barriers and potential solutions in HHT care and research.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03883-1","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:28:10Z","timestamp":1756373290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing racial differences in North American hereditary hemorrhagic telangiectasia study recruitment and care"],"prefix":"10.1186","volume":"20","author":[{"given":"Gabriella","family":"Scott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashlee","family":"Agundiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Hetts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3746-383X","authenticated-orcid":false,"given":"Marie E.","family":"Faughnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Brain Vascular Malformation Consortium HHT Investigator Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"3883_CR1","first-page":"167","volume":"123","author":"WJ Riley","year":"2012","unstructured":"Riley WJ. Health disparities: gaps in access, quality and affordability of medical care. Trans Am Clin Climatol Assoc. 2012;123:167\u201374.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"3883_CR2","unstructured":"National Academies of Sciences, Engineering. and M; Health and Baciu A, Negussie Y, Geller A editors Communities in action: pathways to health equity. Washington (DC): National Academies Press (US); January 11, 2017."},{"issue":"22","key":"3883_CR3","doi-asserted-by":"publisher","first-page":"8343","DOI":"10.3390\/ijerph17228343","volume":"17","author":"W Phillips-Beck","year":"2020","unstructured":"Phillips-Beck W, Eni R, Lavoie JG, Avery Kinew K, Kyoon Achan G, Katz A. Confronting racism within the Canadian healthcare system: systemic exclusion of first nations from quality and consistent care. Int J Environ Res Public Health. 2020;17(22):8343. https:\/\/doi.org\/10.3390\/ijerph17228343. Published 2020 Nov 11.","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"3883_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/0840470418791868","volume":"31","author":"NC Nickel","year":"2018","unstructured":"Nickel NC, Lee JB, Chateau J, Paill\u00e9 M. Income inequality, structural racism, and canada\u2019s low performance in health equity. Healthc Manage Forum. 2018;31(6):245\u201351. https:\/\/doi.org\/10.1177\/0840470418791868.","journal-title":"Healthc Manage Forum"},{"key":"3883_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12939-021-01410-9","volume":"20","author":"DF Mahabir","year":"2021","unstructured":"Mahabir DF, O\u2019Campo P, Lofters A, et al. Experiences of everyday racism in toronto\u2019s health care system: a concept mapping study. Int J Equity Health. 2021;20:74. https:\/\/doi.org\/10.1186\/s12939-021-01410-9.","journal-title":"Int J Equity Health"},{"issue":"1","key":"3883_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41390-022-02240-3","volume":"93","author":"MH Wojcik","year":"2023","unstructured":"Wojcik MH, Bresnahan M, Del Rosario MC, Ojeda MM, Kritzer A, Fraiman YS. Rare diseases, common barriers: disparities in pediatric clinical genetics outcomes. Pediatr Res. 2023;93(1):110\u20137. https:\/\/doi.org\/10.1038\/s41390-022-02240-3.","journal-title":"Pediatr Res"},{"issue":"12","key":"3883_CR7","doi-asserted-by":"publisher","first-page":"989","DOI":"10.7326\/M20-1443","volume":"173","author":"ME Faughnan","year":"2020","unstructured":"Faughnan ME, Mager JJ, Hetts SW, et al. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med. 2020;173(12):989\u20131001. https:\/\/doi.org\/10.7326\/M20-1443.","journal-title":"Ann Intern Med"},{"key":"3883_CR8","doi-asserted-by":"publisher","unstructured":"Chowdhury FN, Chandrarathne GS, Masilamani KD, et al. Links between strokes and hereditary hemorrhagic telangiectasia: a population-based study. Can J Neurol Sci. 2019;46(1):44-50. https:\/\/doi.org\/10.1017\/cjn.2018.360","DOI":"10.1017\/cjn.2018.360"},{"key":"3883_CR9","doi-asserted-by":"crossref","unstructured":"Pierucci P, Lenato GM, Suppressa P, et al. A long diagnostic delay in patients with hereditary haemorrhagic telangiectasia: a questionnaire-based retrospective study. OrphanetJ Rare Dis. 2012;7:33. [PMID: 22676497]","DOI":"10.1186\/1750-1172-7-33"},{"key":"3883_CR10","unstructured":"Akers AL, Ball KL, Clancy M, et al. Brain vascular malformation consortium: overview,progress and future directions. J Rare Disord. 2013;1(1):5."},{"key":"3883_CR11","unstructured":"Statistics Canada. 2017. Toronto [Census metropolitan area], Ontario and Ontario [Province] (table). Census Profile. 2016 Census. Statistics Canada Catalogue no. 98-316-X2016001. Ottawa. Released November 29, 2017. https:\/\/www12.statcan.gc.ca\/census-recensement\/2016\/dp-pd\/prof\/index.cfmLang=E."},{"key":"3883_CR12","unstructured":"Bay Area Census (2010). San Francisco Bay Area. http:\/\/www.bayareacensus.ca.gov\/bayarea.htm."},{"key":"3883_CR13","doi-asserted-by":"crossref","unstructured":"Flanagin A, Frey T, Christiansen SL, AMA Manual of Style Committee. Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA. 2021;326(7):621\u2013627. http:\/\/www.bayareacensus.ca.gov\/bayarea.htm.","DOI":"10.1001\/jama.2021.13304"},{"key":"3883_CR14","doi-asserted-by":"publisher","unstructured":"Sison, Cristina P., and Joseph Glaz. Simultaneous confidence intervals and sample size determination for multinomial proportions. J Am Stat Assoc. 1995;90(429):366\u201369. https:\/\/doi.org\/10.2307\/2291162.","DOI":"10.2307\/2291162"},{"key":"3883_CR15","doi-asserted-by":"publisher","unstructured":"May, W. L., & Johnson, W. D. Constructing two-sided simultaneous confidence intervals for multinomial proportions for small counts in a large number of cells. J Stat Softw. 2000;5(6), 1\u201324. https:\/\/doi.org\/10.18637\/jss.v005.i06.","DOI":"10.18637\/jss.v005.i06"},{"key":"3883_CR16","unstructured":"StataCorp. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC. 2017."},{"key":"3883_CR17","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2022. https:\/\/www.R-project.org\/."},{"key":"3883_CR18","doi-asserted-by":"publisher","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"3883_CR19","doi-asserted-by":"publisher","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"3883_CR20","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-Mart\u00ednez R, Iriarte A, Mora-Luj\u00e1n JM, et al. Current HHT genetic overview in Spain and its phenotypic correlation: data from RiHHTa registry. Orphanet J Rare Dis. 2020;15(1):138. Published 2020 Jun 5. https:\/\/doi.org\/10.1186\/s13023-020-01422-8.","DOI":"10.1186\/s13023-020-01422-8"},{"key":"3883_CR21","doi-asserted-by":"publisher","unstructured":"Kitonyi GW, Wambugu PM, Oburra HO, Ireri JM. Hereditary haemorrhagic telangiectasia in a black adult male: case report.\u00a0East Afr Med J. 2008;85(8):412-416. https:\/\/doi.org\/10.4314\/eamj.v85i8.9659.","DOI":"10.4314\/eamj.v85i8.9659"},{"key":"3883_CR22","doi-asserted-by":"publisher","unstructured":"Komiyama, M., Ishiguro, T., Yamada, O.\u00a0et al.\u00a0Hereditary hemorrhagic telangiectasia in Japanese patients.\u00a0J Hum Genet\u00a059, 37\u201341 (2014). https:\/\/doi.org\/10.1038\/jhg.2013.113.","DOI":"10.1038\/jhg.2013.113"},{"key":"3883_CR23","doi-asserted-by":"publisher","unstructured":"Brinjikji W, Wood CP, Lanzino G, et al. High rates of bleeding complications among hospitalized patients with hereditary hemorrhagic telangiectasia in the United States.\u00a0Ann Am Thorac Soc. 2016;13(9):1505-1511. https:\/\/doi.org\/10.1513\/AnnalsATS.201603-200OC.","DOI":"10.1513\/AnnalsATS.201603-200OC"},{"key":"3883_CR24","doi-asserted-by":"publisher","unstructured":"Galiatsatos P, Wilson C, O'Brien J, et al. A lack of race and ethnicity data in the treatment of hereditary hemorrhagic telangiectasia: a systematic review of intravenous bevacizumab efficacy.\u00a0Orphanet J Rare Dis. 2022;17(1):220. Published 2022 Jun 13. https:\/\/doi.org\/10.1186\/s13023-022-02371-0.","DOI":"10.1186\/s13023-022-02371-0"},{"key":"3883_CR25","doi-asserted-by":"publisher","unstructured":"Mora-Luj\u00e1n JM, Iriarte A, Alba E, et al. Gender differences in hereditary hemorrhagic telangiectasia severity. Orphanet J Rare Dis. 2020;15(1):63. Published 2020 Mar 2. https:\/\/doi.org\/10.1186\/s13023-020-1337-5","DOI":"10.1186\/s13023-020-1337-5"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03883-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03883-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03883-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:28:14Z","timestamp":1756373294000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03883-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3883"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03883-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"28 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional ethics review board at each recruiting center of the BVMC. SMH REB#20\u2013053 is the approval number at the lead site at St. Michael\u2019s Hospital. All subjects provided informed consent for participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"461"}}